contraindications for glp 1 agonists GLP-1 receptor are transforming diabetes care by improving blood sugar control, supporting weight loss, and reducing cardiovascular risk when used appropriately. Evidence-based therapy selection, correct dosing, and patient counseling are Weight loss medications: Video, Uses,

Read more below To view or add a comment, sign in Latest News : "LDL-C, Lp(a) & Hs-CRP Predict CV Events Synergistically" New UK Biobank data shows LDL-C, Lp(a), and Hs-CRP work together to predict cardiovascular events, even in patients on cholesterol-lowering drugs

A 2012 study published in Journal of Pharmacology and Experimental Therapeutics demonstrated that a seven-day dihexa dosing protocol produced cognitive improvements in rodent models that persisted for at least 30 days post-treatment, despite the compound being undetectable in plasma within 12 hours of the final dose

11 integrin stimulates myofibroblast differentiation in diabetic cardiomyopathy

found that GLP-1 RAs are associated with an increased risk of gallbladder and biliary diseases (including cholelithiasis and cholecystitis), particularly at higher doses, longer treatment durations, and when used for weight loss [129]

DR version of HA is that it's a huge polymer (big molecule from repeated subunits) found in the skin that acts as a sponge helping the skin to hold onto water, being plump and elastic